EyePoint Pharmaceuticals Files 8-K on Financials

Ticker: EYPT · Form: 8-K · Filed: Aug 6, 2025 · CIK: 1314102

Eyepoint Pharmaceuticals, Inc. 8-K Filing Summary
FieldDetail
CompanyEyepoint Pharmaceuticals, Inc. (EYPT)
Form Type8-K
Filed DateAug 6, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: financial-reporting, 8-K, company-update

Related Tickers: EYPT

TL;DR

EYPT filed an 8-K on Aug 6th detailing financial results and exhibits.

AI Summary

EyePoint Pharmaceuticals, Inc. filed an 8-K on August 6, 2025, reporting on its results of operations and financial condition, and filing financial statements and exhibits. The company, formerly known as pSivida Corp. and pSivida LTD, is incorporated in Delaware and headquartered in Watertown, Massachusetts.

Why It Matters

This filing provides investors with crucial updates on EyePoint Pharmaceuticals' financial performance and condition, which can influence investment decisions.

Risk Assessment

Risk Level: low — This is a routine filing of financial information and does not indicate any immediate or significant risks.

Key Players & Entities

  • EyePoint Pharmaceuticals, Inc. (company) — Registrant
  • pSivida Corp. (company) — Former company name
  • pSivida LTD (company) — Former company name
  • August 06, 2025 (date) — Date of earliest event reported
  • Delaware (jurisdiction) — State of incorporation
  • Watertown, Massachusetts (location) — Principal executive offices

FAQ

What is the primary purpose of this 8-K filing for EyePoint Pharmaceuticals, Inc.?

The primary purpose is to report on the company's Results of Operations and Financial Condition, and to file Financial Statements and Exhibits.

When was the earliest event reported in this filing?

The earliest event reported was on August 06, 2025.

What were EyePoint Pharmaceuticals, Inc.'s former company names?

EyePoint Pharmaceuticals, Inc. was formerly known as pSivida Corp. and pSivida LTD.

In which state is EyePoint Pharmaceuticals, Inc. incorporated?

The company is incorporated in Delaware.

Where are EyePoint Pharmaceuticals, Inc.'s principal executive offices located?

The principal executive offices are located at 480 Pleasant Street, Suite C400, Watertown, Massachusetts, 02472.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on August 6, 2025 regarding EyePoint Pharmaceuticals, Inc. (EYPT).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.